Safety and Effectiveness of Laser in Situ Keratomileusis Using the Teneo 317 Model 2 for Correcting Myopia and Myopic Astigmatism: Results of the U.S. FDA Clinical Trial
LASIK performed using a new aspheric ablation profile of the Technolas Teneo 317 (Model 2) excimer laser is safe and effective for correcting myopia and myopic astigmatism, yielding excellent visual and refractive outcomes that were stable over 9 months. <b>[<i>J Refract Surg</i>. 2024;40(8):e544-e553.]</b>.
Authors
- Gregg Feinerman
- Nisha Kumar
- Y. Ralph Chu
- Mark Lobanoff (ORCID: https://orcid.org/0000-0003-2230-7532)
- Lester O Hosten
- Karl Stonecipher (ORCID: https://orcid.org/0000-0003-4050-9357)
- Michael Endl
- George O. Waring
Institutions
- Digital Catapult (GB)
Publication Details
- Journal
- Journal of Refractive Surgery
- Published
- 2024-08-01
- DOI
- https://doi.org/10.3928/1081597x-20240611-03
- Citations
- 4
- Primary Topic
- Corneal surgery and disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.62
Funders
- Allergan